Pharmacokinetics of abuse deterrent, extended release once-a-day dosage forms of levorphanol: a single-dose, 5-way crossover study
Najib Babul(University of Nevada, Las Vegas), Sarah Brown(University of Leeds), Amanda McNaughton(ImQuest BioSciences (United States)), Viola Mae Young(ImQuest BioSciences (United States)), M. Bakhshaee(ImQuest BioSciences (United States)), H. Kao(ImQuest BioSciences (United States))
Cited by 0
Related Papers
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
|The Lancet|2010|640
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
|The Lancet|2015|477
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
|The Lancet Oncology|2013|392
Clinical development of new drug–radiotherapy combinations
|Nature Reviews Clinical Oncology|2016|317